Salarius Pharmaceuticals
SLRX
SLRX
15 hedge funds and large institutions have $607K invested in Salarius Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less capital invested
Capital invested by funds: $637K → $607K (-$30K)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$105K | |
| 2 | +$44K | |
| 3 | +$32K | |
| 4 |
Squarepoint
New York
|
+$10K |
| 5 |
Two Sigma Investments
New York
|
+$10K |
Top Sellers
| 1 | -$4K | |
| 2 | -$2K | |
| 3 | -$2K | |
| 4 |
Morgan Stanley
New York
|
-$2K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2K |